AUA 2020 Virtual Program
AUA 2020 Prostate Cancer
- AUA 2020: Pembrolizumab Plus Enzalutamide in Abiraterone-Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer: Updated Results From KEYNOTE-365 Cohort C
- AUA 2020: Comparison of Prostate-Specific Membrane Antigen-Targeted Radionuclide Therapy with Lutetium-177 via Antibody J591 vs. Small Molecule Ligand PSMA-617
- AUA 2020: Abiraterone is Associated with Higher Odds of Cardiac Complications Compared to Enzalutamide
- AUA 2020: Effect of Cabazitaxel vs. Abiraterone or Enzalutamide on Patient-Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Pre-Planned EQ-5D-5L Analysis of the CARD Study
- AUA 2020: Decision-Analytic Modeling Study of the PRECISION Trial: Does Pre-Biopsy MRI Do More Good Than Harm?
AUA 2020 Bladder Cancer
- AUA 2020: Identifying the Frequency of Actionable Genomic Alterations in Localized and Metastatic Upper Tract Urothelial Carcinoma
- AUA 2020: Inherited Cancer Predisposition Gene Variants in Patients with Non-Muscle Invasive Bladder Cancer
- AUA 2020: Cost-Effectiveness of Maintenance BCG for Intermediate and High Risk Non-Muscle Invasive Bladder Cancer
- AUA 2020: Expanding Kidney-Sparing Options for Patients with Low-Grade Upper Tract Urothelial Cancer
- AUA 2020: A Phase III Study to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec for Patients with High-Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer: Papillary Disease Cohort Results
AUA 2020 Kidney Cancer
- AUA 2020: Benchmarking Current Nephrectomy Practice in Malignant Disease in England: An Analysis of the BAUS Complex Operation Registry
- AUA 2020: Surveillance and Communication of Surgical Results in Localized Renal Cell Carcinoma, Results from a Large International Patient Survey
- AUA 2020: Long Term Oncologic Outcomes of Surgically Treated Renal Oncocytoma
- AUA 2020: Multicenter Comparison of Outcomes for Clinical and Pathologic T3a Renal Cell Carcinoma
- AUA 2020: Nephrology Referral Practices Surrounding Renal Cancer Surgery
AUA 2020 Testicular and Penile Cancer
AUA 2020 Bladder Health
- AUA 2020: Global Variation in Cancer Detection Rates in Patients referred to Secondary Care with Haematuria: Do Some Over-Investigate? Results from the IDENTIFY Collaborative Study
- AUA Guidelines 2020: Microhematuria
- AUA 2020: Complicated UTI Management
- AUA 2020: The Use of Peripheral Tibial Nerve Stimulation as an Alternative Treatment for Overactive Bladder/Incontinence
- AUA 2020: Guidelines Based Medical Management & Treatment of Erectile Dysfunction
AUA 2020 Press Releases
- AUA Announces Updates to Clinical Guidance for Surgical Management of LUTS Attributed to BPH
- Leading Organizations Release Joint Clinical Guideline for Diagnosis and Evaluation of Microhematuria
- The American Urological Association (AUA), Sexual Medicine Society of North America (SMSNA) Release New Disorders of Ejaculation Guideline
- Leading Organizations Release New Clinical Guideline on Advanced Prostate Cancer